- Issuer ticker
-
IRMD
- Reported as of
-
03 Sep 2026
- Net transaction value
-
-$122,622
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
08 Sep 2026, 16:35:35 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Monty Allen
Key filing fact
Monty K. Allen filed Form 4 for IRADIMED CORP (IRMD) on 08 Sep 2026.
Key facts
- This page summarizes Monty K. Allen's Form 4 filing for IRADIMED CORP (IRMD).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Sep 2026, 16:35.
Change
- Previous filing in this sequence was filed on 13 Feb 2026.
- Current net transaction value: -$122,622.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001253352
Primary reporting owner
ALLEN MONTY K
- Relationship
-
Director
- Address
- C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO
- Signature
- /s/ Monty Allen
- Signature date
- 08 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRMD
transaction
Common Stock
Sale
- Transaction value
- $87,650
- Shares
- -1,014
- Change %
- -4.8%
- Price
-
$86.44
- Shares after
- 19,986
- Date
- 03 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
IRMD
transaction
Common Stock
Sale
- Transaction value
- $34,972
- Shares
- -405
- Change %
- -2%
- Price
-
$86.35
- Shares after
- 19,581
- Date
- 03 Sep 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote